CVS - CVS Health Corporation

NYSE - Nasdaq Real Time Price. Currency in USD
64.42
+0.79 (+1.24%)
As of 12:53PM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close63.63
Open64.18
Bid64.31 x 900
Ask64.31 x 800
Day's Range64.11 - 64.69
52 Week Range51.72 - 82.15
Volume3,717,991
Avg. Volume8,045,054
Market Cap84.268B
Beta (3Y Monthly)1.00
PE Ratio (TTM)17.65
EPS (TTM)3.65
Earnings DateNov 4, 2019 - Nov 8, 2019
Forward Dividend & Yield2.00 (3.14%)
Ex-Dividend Date2019-07-24
1y Target Est69.96
Trade prices are not sourced from all markets
  • ACCESSWIRE

    The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of MMM, NGHC and CVS

    NEW YORK, NY / ACCESSWIRE / September 20, 2019 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate ...

  • State Senator Ling Ling Chang and LA Clippers Power Forward Mfiondu Kabengele Helps CVS Health Kick Off Free Health Screenings in Los Angeles
    PR Newswire

    State Senator Ling Ling Chang and LA Clippers Power Forward Mfiondu Kabengele Helps CVS Health Kick Off Free Health Screenings in Los Angeles

    LOS ANGELES, Sept. 20, 2019 /PRNewswire/ -- As part of a commitment to building healthier communities, CVS Health (CVS) celebrated the expansion of its annual Project Health free health screening campaign with a community event that took place on Thursday, September 19th at CVS Pharmacy, 2011 E. La Palma Ave., Anaheim. Thursday's event was one of 93 free health screenings taking place in the Los Angeles area between now and the end of the year. State Senator Ling Ling Chang and LA Clippers power forward Mfiondu Kabengele were on hand at the event, along with community members and CVS Pharmacy field leadership to discuss the importance of being proactive about your health, eating well and not smoking.

  • ACCESSWIRE

    CVS Health Corporation (CVS), NetApp, Inc. (NTAP) & SAExploration Holdings, Inc. (SAEX) - Upcoming Deadlines - Bronstein, Gewirtz & Grossman, LLC

    NEW YORK, NY / ACCESSWIRE / September 20, 2019 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may contact Peretz Bronstein, Esq. If you suffered a loss, you can request that the Court appoint you as lead plaintiff.

  • Miami Heat's Bam Adebayo Helps CVS Health Kick Off Free Health Screenings in Miami
    PR Newswire

    Miami Heat's Bam Adebayo Helps CVS Health Kick Off Free Health Screenings in Miami

    MIAMI, Sept. 20, 2019 /PRNewswire/ -- As part of a commitment to building healthier communities, CVS Health (CVS) celebrated the expansion of its annual Project Health free health screening campaign with a community event that took place on Thursday, September 19th at CVS Pharmacy, 8330 Mills Dr., Miami. Thursday's event was one of 48 free health screenings taking place in the Miami area between now and the end of the year.

  • World Champion Swimmer Chase Kalisz Helps CVS Health Kick Off Free Health Screenings in Atlanta
    PR Newswire

    World Champion Swimmer Chase Kalisz Helps CVS Health Kick Off Free Health Screenings in Atlanta

    ATLANTA, Sept. 20, 2019 /PRNewswire/ -- As part of a commitment to building healthier communities, CVS Health (CVS) celebrated the expansion of its annual Project Health free health screening campaign with a community event that took place on Thursday, September 19th at CVS Pharmacy, 895 Ralph Abernathy Blvd., Atlanta. Thursday's event was one of 48 free health screenings taking place in the Atlanta area between now and the end of the year.

  • ACCESSWIRE

    CLASS ACTION UPDATE for EGBN, CVS and MGNX: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

    NEW YORK, NY / ACCESSWIRE / September 19, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. To determine ...

  • GlobeNewswire

    CVS NOTICE: ROSEN, A LEADING LAW FIRM, Announces Filing of Securities Class Action Lawsuit Against CVS Health Corporation

    NEW YORK, Sept. 19, 2019 -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of all former Aetna Inc. shareholders.

  • ACCESSWIRE

    FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of CVS, MGNX and CADE

    CEDARHURST, NY / ACCESSWIRE / September 19, 2019 / The securities litigation law firm of Kuznicki Law PLLC issues the following notice on behalf of shareholders of the following publicly traded companies. Shareholders who purchased shares in these companies during the dates listed below are encouraged to contact the firm regarding possible appointment as lead plaintiff and a preliminary estimate of their recoverable losses. If you wish to choose counsel to represent you and the class, you must apply to be appointed lead plaintiff and be selected by the Court.

  • ACCESSWIRE

    IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against CVS Health Corporation and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

    LOS ANGELES, CA / ACCESSWIRE / September 19, 2019 / The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against CVS Health Corporation (“CVS” ...

  • What Does CVS Health Corporation's (NYSE:CVS) Share Price Indicate?
    Simply Wall St.

    What Does CVS Health Corporation's (NYSE:CVS) Share Price Indicate?

    CVS Health Corporation (NYSE:CVS) saw a double-digit share price rise of over 10% in the past couple of months on the...

  • GlobeNewswire

    The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of MMM, GNLN, IFF and CVS

    The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

  • PR Newswire

    CVS Health Offering Nearly 600 Free Wellness Screening Events in 12 Markets Across U.S

    WOONSOCKET, R.I., Sept. 19, 2019 /PRNewswire/ -- Building on its impact over the past decade, CVS Health (CVS) will expand its Project Health campaign to target more underserved and underinsured communities in 2019, with an aim of reaching more at-risk populations with free health and wellness screenings. Project Health offers a no-cost comprehensive health assessment, including blood pressure, Body Mass Index (BMI), glucose and total cholesterol screenings, which can detect early risks for chronic conditions like diabetes, hypertension, and heart disease. Since it was founded in 2006, Project Health has delivered more than $127 million in free health care services to nearly 1.7 million Americans.

  • Cigna Expands Health Care Exchange Offerings to New Markets
    Zacks

    Cigna Expands Health Care Exchange Offerings to New Markets

    Cigna (CI) expands the health care exchange plan to new regions beginning 2020 to enrich customer experience.

  • GlobeNewswire

    SHAREHOLDER ALERT: CLAIMSFILER REMINDS CVS, GVA, IFF, PS INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits

    NEW ORLEANS, Sept. 18, 2019 -- ClaimsFiler, a FREE shareholder information service, reminds investors of pending deadlines in the following securities class action lawsuits:.

  • ACCESSWIRE

    The Gross Law Firm Announces Class Actions on Behalf of Shareholders of EGBN, CVS and MDP

    NEW YORK, NY / ACCESSWIRE / September 18, 2019 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment.

  • ACCESSWIRE

    CVS Health Corporation (CVS), NetApp, Inc. (NTAP) & SAExploration Holdings, Inc. (SAEX) - Upcoming Class Action Deadlines - Bronstein, Gewirtz & Grossman, LLC

    NEW YORK, NY / ACCESSWIRE / September 18, 2019 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may contact Peretz Bronstein, Esq. If you suffered a loss, you can request that the Court appoint you as lead plaintiff.

  • ACCESSWIRE

    SHAREHOLDER ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against CVS Health Corporation- CVS

    NEW YORK, NY / ACCESSWIRE / September 18, 2019 / Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of CVS Health Corporation (NYSE:CVS) ...

  • CVS Health (CVS) Gains But Lags Market: What You Should Know
    Zacks

    CVS Health (CVS) Gains But Lags Market: What You Should Know

    CVS Health (CVS) closed the most recent trading day at $63.47, moving +0.06% from the previous trading session.

  • InvestorPlace

    Why Rite Aid Stock Will Probably Underperform Alternatives

    There's an intriguing case for Rite Aid (NYSE:RAD) stock at the moment. For a long time, bulls have been awaiting a turnaround that can boost Rite Aid stock, and a new CEO has finally come on board. Meanwhile, with the RAD stock price down over 95% from its early 2017 highs, the stock's valuation seems like it should be reasonable.Source: J. Michael Jones / Shutterstock.com And there is an intriguing, albeit high-risk, positive case for RAD stock at these levels.The current RAD stock price of $7.50 indicates a market cap of just under $400 million. The company's net debt (adjusted for the pending sale of two distribution centers) is over $3.2 billion. If the company's enterprise value of roughly $3.6 billion rises by just 10%, Rite Aid stock will almost double.InvestorPlace - Stock Market News, Stock Advice & Trading TipsBut I've been a longtime bear on RAD stock for reasons that go to the heart of the current bull case. The easy bull argument is that former CEO John Standley ran Rite Aid into the ground. Certainly, the revised deal with Walgreens (NASDAQ:WBA) was a massive disappointment. But the pressures on Rite Aid are the same pressures facing the rest of the industry.And so it's a bit too simplistic to believe that a new CEO can simply "fix" Rite Aid all that quickly amid the pressures on the sector. Meanwhile, the company's debt creates a major risk to Rite Aid stock going forward. Much like General Electric (NYSE:GE), a popular turnaround pick, new leadership can help RAD stock. But there are significant obstacles that add risk to the company's outlook. * 7 Momentum Stocks to Buy On the Dip Moreover, there are other ways, besides buying RAD stock, to bet on the turnaround of the sector. At the very least, those who are bullish on RAD stock should consider those options. Not Just Rite Aid's ProblemIt's important to put the performance of Rite Aid stock in the context of the pharmacy space. The entire industry is struggling right now. Fred's (NASDAQ:FRED), which was going to buy Rite Aid stores as part of the original Walgreens takeover, just filed for bankruptcy. Walgreens stock touched a five-year low last month. CVS Health (NYSE:CVS) bounced off its lowest levels in six years this spring.The RAD stock price has fallen further than other pharmacy equities. But that's because Rite Aid has more debt than its peers.In fact, since the beginning of 2018, Rite Aid stock has fallen 81%. But its enterprise value (its market cap plus the face value of its debt) is down only 22%. Over the same period, Walgreens' EV has dropped almost 20%, but its shares are down only 24%.It's clear that the entire sector is struggling with pressures. Reimbursement rates from insurance companies are falling. And sales of OTC products, perhaps due to competition from the likes of Amazon.com (NASDAQ:AMZN), remain weak.Those pressures, combined with higher fixed costs, have dragged down the sector's profits. Indeed, the operating profit of Walgreens' U.S. pharmacy business fell in the third quarter. Should Investors Buy CVS or Walgreens Instead of Rite Aid Stock?For RAD stock to finally rally, those industry pressures have to ease. But if that happens, investors can benefit by buying CVS or Walgreens instead. In terms of EV/EBITDA, Rite Aid stock is only modestly cheaper than CVS and Walgreens. As a result, investors would likely be better off buying one of the larger companies, which are big enough to muddle through if the environment doesn't improve.In an uber-bullish scenario, Rite Aid stock will no doubt outperform its peers (as it did after the financial crisis). That's because not many shares of RAD stock are available, so Rite Aid stock price can jump tremendously if its EBITDA increases and its free cash flow and net income move into the black from their current stagnation.But if the sector remains stable, Rite Aid stock will likely continue to underperform. And with $3 billion in debt due in 2023, and the company's net debt over six times its annual EBITDA, RAD may not be able to refinance.Rite Aid stock will outperform in a bullish scenario if the industry's pressures finally ease. In any other environment, Walgreens or CVS will likely do better. So investors who want to bet on the industry have to at least consider buying the shares of those larger operators instead. What Level Does the RAD Stock Price Need to Reach to Outperform Rite Aid's Bonds?There's another option to consider: Rite Aid's bonds. Like the RAD stock price, the prices of Rite Aid's bonds are at multi-year lows.The 6.125% bonds that mature in April 2023 have a current price of 79 and an annual yield to maturity of 13.7%. Longer-dated issues are potentially more attractive. The 7.7% February 2027 bonds are priced at 50, with a YTM of 21.2%.The 6.875% bonds that mature in 2028 have a similar price, with a yield to maturity of 18%.The bonds are less risky than Rite Aid stock, since secured bonds may have some value even if RAD goes bankrupt.And it's important to realize that RAD stock needs to climb substantially just to outperform those bonds. To top the April 2023 bonds, RAD stock price would need to reach $12. To beat the 2027 bonds, the RAD stock price would need to soar over 320%.The bond prices have an impact on Rite Aid stock because high demand for the bonds may cause demand for the equity to be low. And it's worth noting for near-term traders that the bond prices haven't moved lately, even as the RAD stock price has bounced 50% off its August lows. Consequently, the bonds are more attractive than they were a month ago.In the most bullish scenario, Rite Aid stock will outperform Rite Aid's debt. It will also outperform CVS, and Walgreens, and probably over 90% of the stocks in the market. The sheer size of the company's debt is why RAD stock has fallen so far - and why RAD stock can soar if it's finally able to lower its debt.But there's a long path to that bullish scenario, and some outside help is needed. And in anything less than a blue-sky outcome, investors likely will do better if they buy alternatives to Rite Aid stock.As of this writing, Vince Martin has no positions in any securities mentioned. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Momentum Stocks to Buy On the Dip * 7 Dow Titans Breaking Higher * 5 Growth Stocks to Sell as Rates Move Higher The post Why Rite Aid Stock Will Probably Underperform Alternatives appeared first on InvestorPlace.

  • ACCESSWIRE

    FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of EGBN, GNLN and CVS

    CEDARHURST, NY / ACCESSWIRE / September 17, 2019 / The securities litigation law firm of Kuznicki Law PLLC issues the following notice on behalf of shareholders of the following publicly traded companies. Shareholders who purchased shares in these companies during the dates listed below are encouraged to contact the firm regarding possible appointment as lead plaintiff and a preliminary estimate of their recoverable losses. If you wish to choose counsel to represent you and the class, you must apply to be appointed lead plaintiff and be selected by the Court.

  • ACCESSWIRE

    SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against CVS Health Corporation and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

    LOS ANGELES, CA / ACCESSWIRE / September 17, 2019 / The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against CVS Health Corporation (“CVS” ...

  • GlobeNewswire

    INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against CVS Health Corporation and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

    The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against CVS Health Corporation (“CVS” or “the Company”) (NYSE: CVS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Based on these facts, the Company’s public statements were false and materially misleading throughout the acquisition period.

  • ACCESSWIRE

    CLASS ACTION UPDATE for GNLN, CURLF and CVS: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

    NEW YORK, NY / ACCESSWIRE / September 17, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. To determine your eligibility and get free access to our shareholder support tools that provide you with case updates, automated loss calculations and claims recovery assistance, please contact the firm via the links below. Lawsuit on behalf of: investors who purchased on behalf of all who purchased or otherwise acquired Greenlane common stock pursuant or traceable to the registration statement and prospectus issued in connection with Greenlane’s April 2019 initial public offering.

  • Zacks.com featured highlights include: Anixter International, CVS Health, AmerisourceBergen, AECOM and Best Buy
    Zacks

    Zacks.com featured highlights include: Anixter International, CVS Health, AmerisourceBergen, AECOM and Best Buy

    Zacks.com featured highlights include: Anixter International, CVS Health, AmerisourceBergen, AECOM and Best Buy